[CRISPR-Cas9, germinal cells and human embryo]

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• CRISPR-Cas9 is a molecular tool enabling targeted DNA modifications.
• This technology has broad applications in research, including generating transgenic animals.
• Experimental use in human embryos shows promise but raises safety concerns.

Purpose of the Study:

• To evaluate the performance and applications of CRISPR-Cas9 gene editing.
• To explore the potential of CRISPR-Cas9 in human clinical applications.
• To address the scientific and ethical considerations of germline gene therapy.

Main Methods:

• Utilizing CRISPR-Cas9 for targeted genome modification.
• Generating transgenic animals via zygotic stage genome editing.
• Experimental application and assessment in human embryos.

Main Results:

• CRISPR-Cas9 demonstrates significant utility in research settings.
• The technology has been experimentally tested on human embryos.
• Potential medical applications are identified, but efficacy and safety remain uncertain.

Conclusions:

• CRISPR-Cas9 holds promise for future human therapies.
• Current uncertainties regarding safety and efficacy preclude short-term germline gene therapy.
• A thorough evaluation of scientific and ethical issues is essential before clinical implementation.